Takeda Pharmaceutical Co. Ltd.

Earnings Per Share Growth (%)-88%
Cost of Goods Sold (US$ Millions)$4,448
Current Liabilities (US$ Millions)$6,995
Total Assets (US$ Millions)$11,412
Long Term Debt$4,484
Return on Equity3.75%
Revenue (US$ Millions)$15,014
Total Company Assets$31,767
Revenue Growth (%)1.66%
Net Income (US$ Millions)$666
Earnings Per Share (US$)($88)
Total Equity (US$ Millions)$16,188
Profit Margin (%)4.44%
Debt To Equity Ratio (%)0.28%
Inventory Turnover$2,110